Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lock Hansen

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2009
Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide studySøren Skøtt Andersen, Morten Lock Hansen, Gunnar H Gislason, et al.
The American Journal of Cardiology|September 17, 2013
Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of ageMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
The American Journal of Medicine|May 15, 2012
Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Deirdre A Lane, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 20, 2014
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013Jonas Bjerring Olesen, Rikke Sørensen, Morten Lock Hansen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2015
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort studyLaila Staerk, Gunnar H Gislason, Gregory Y H Lip, et al.
Circulation|August 8, 2012
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort studyMorten Lamberts, Jonas Bjerring Olesen, Martin Huth Ruwald, et al.
BMJ Open|September 4, 2023
Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort studyChristopher Ryan Zörner, Jannik Pallisgaard, Anne-Marie Schjerning, et al.
Circulation|June 14, 2013
Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study"Morten Lamberts, Jonas Bjerring Olesen, Martin Huth Ruwald, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 8, 2015
Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settingsAnders Pretzmann Mikkelsen, Morten Lock Hansen, Jonas Bjerring Olesen, et al.
European Heart Journal Open|November 27, 2025
Characteristics, trends, and outcomes of ablation for persistent atrial fibrillation: a Danish cohort studyLise Da Riis-Vestergaard, Jacob Tønnesen, Martin H Ruwald, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2009
Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide studySøren Skøtt Andersen, Morten Lock Hansen, Gunnar H Gislason, et al.
The American Journal of Cardiology|September 17, 2013
Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of ageMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
The American Journal of Medicine|May 15, 2012
Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Deirdre A Lane, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 20, 2014
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013Jonas Bjerring Olesen, Rikke Sørensen, Morten Lock Hansen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2015
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort studyLaila Staerk, Gunnar H Gislason, Gregory Y H Lip, et al.
Circulation|August 8, 2012
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort studyMorten Lamberts, Jonas Bjerring Olesen, Martin Huth Ruwald, et al.
BMJ Open|September 4, 2023
Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort studyChristopher Ryan Zörner, Jannik Pallisgaard, Anne-Marie Schjerning, et al.
Circulation|June 14, 2013
Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study"Morten Lamberts, Jonas Bjerring Olesen, Martin Huth Ruwald, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 8, 2015
Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settingsAnders Pretzmann Mikkelsen, Morten Lock Hansen, Jonas Bjerring Olesen, et al.
European Heart Journal Open|November 27, 2025
Characteristics, trends, and outcomes of ablation for persistent atrial fibrillation: a Danish cohort studyLise Da Riis-Vestergaard, Jacob Tønnesen, Martin H Ruwald, et al.
Pageof 14